Faustmann; Jiri

Patent Applications and Registrations

Patent applications and USPTO patent grants for Faustmann; Jiri.The latest application filed is for "polymorphs of dasatinib and process for preparation thereof".

Company Profile

0.2.12

Faustmann; Jiri - Opava-Kylesovice CZ
Faustmann; Jiri - Opava-6 CZ
Faustmann; Jiri - Opava CZ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solid state forms of obeticholic acid salts Grant 10,611,793 - Vraspir , et al.	2020-04-07
Polymorphs of fluticasone furoate and process for preparation thereof Grant 8,148,353 - MacDonald , et al. April 3, 2	2012-04-03
Polymorphs Of Dasatinib And Process For Preparation Thereof App 20100256158 - SIMO; Ondrej ; et al.	2010-10-07
Polymorphs of fluticasone furoate and process for preparation thereof App 20100130458 - Macdonald; Peter Lindsay ; et al.	2010-05-27
Crystalline Forms Of Erlotinib Base And Erlotinib Hcl App 20100004449 - GAVENDA; Ales ; et al.	2010-01-07
Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form alpha App 20090264438 - Jegorov; Alexandr ; et al.	2009-10-22
Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCI App 20090131665 - Gavenda; Ales ; et al.	2009-05-21
Crystalline forms of Erlotinib HCI and formulations thereof App 20090124642 - Canavesi; Augusto ; et al.	2009-05-14
Polymorphs Of Dasatinib And Process For Preparation Thereof App 20090118297 - SIMO; Ondrej ; et al.	2009-05-07
Amorphous Erlotinib, processes for the preparation thereof, and processes to prepare additional forms of Erlotinib App 20090012295 - Gavenda; Ales ; et al.	2009-01-08
Process for Isolation of Mycophenolic Acid App 20080293110 - Cvak; Ladislav ; et al.	2008-11-27
Isolation of Galanthamine From Biological Material App 20080262223 - Cvak; Ladislav ; et al.	2008-10-23
Method for reducing impurity level in mycophenolic acid fermentation App 20080254520 - Gulyas; Eva ; et al.	2008-10-16
Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form alpha App 20080090833 - Jegorov; Alexandr ; et al.	2008-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.